Global Intravenous (IV) Iron Drugs Market Research Report Forecast 2017-2021 Chapter 1 Intravenous (IV) Iron Drugs Market Overview 1.1 Product Overview and Scope of Intravenous (IV) Iron Drugs 1.2 Intravenous (IV) Iron Drugs Market Segmentation by Type 1.2.1 Global Production Market Share of Intravenous (IV) Iron Drugs by Type in 2015 1.2.1 Type 1 1.2.2 Type 2 1.2.3 Type 3 1.3 Intravenous (IV) Iron Drugs Market Segmentation by Application 1.3.1 Intravenous (IV) Iron Drugs Consumption Market Share by Application in 2015 1.3.2 Application 1 1.3.3 Application 2 1.3.4 Application 3 1.4 Intravenous (IV) Iron Drugs Market Segmentation by Regions 1.4.1 North America 1.4.2 China 1.4.3 Europe 1.4.4 Southeast Asia 1.4.5 Japan 1.4.6 India 1.5 Global Market Size (Value) of Intravenous (IV) Iron Drugs (2012-2021) Chapter 2 Global Economic Impact on Intravenous (IV) Iron Drugs Industry 2.1 Global Macroeconomic Environment Analysis 2.1.1 Global Macroeconomic Analysis 2.1.2 Global Macroeconomic Environment Development Trend 2.2 Global Macroeconomic Environment Analysis by Regions Chapter 3 Global Intravenous (IV) Iron Drugs Market Competition by Manufacturers 3.1 Global Intravenous (IV) Iron Drugs Production and Share by Manufacturers (2015 and 2016) 3.2 Global Intravenous (IV) Iron Drugs Revenue and Share by Manufacturers (2015 and 2016) 3.3 Global Intravenous (IV) Iron Drugs Average Price by Manufacturers (2015 and 2016) 3.4 Manufacturers Intravenous (IV) Iron Drugs Manufacturing Base Distribution, Production Area and Product Type 3.5 Intravenous (IV) Iron Drugs Market Competitive Situation and Trends 3.5.1 Intravenous (IV) Iron Drugs Market Concentration Rate 3.5.2 Intravenous (IV) Iron Drugs Market Share of Top 3 and Top 5 Manufacturers 3.5.3 Mergers & Acquisitions, Expansion Chapter 4 Global Intravenous (IV) Iron Drugs Production, Revenue (Value) by Region (2012-2017) 4.1 Global Intravenous (IV) Iron Drugs Production by Region (2012-2017) 4.2 Global Intravenous (IV) Iron Drugs Production Market Share by Region (2012-2017) 4.3 Global Intravenous (IV) Iron Drugs Revenue (Value) and Market Share by Region (2012-2017) 4.4 Global Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) 4.5 North America Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) 4.6 Europe Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) 4.7 China Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) 4.8 Japan Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) 4.9 Southeast Asia Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) 4.10 India Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) Chapter 5 Global Intravenous (IV) Iron Drugs Supply (Production), Consumption, Export, Import by Regions (2012-2017) 5.1 Global Intravenous (IV) Iron Drugs Consumption by Regions (2012-2017) 5.2 North America Intravenous (IV) Iron Drugs Production, Consumption, Export, Import by Regions (2012-2017) 5.3 Europe Intravenous (IV) Iron Drugs Production, Consumption, Export, Import by Regions (2012-2017) 5.4 China Intravenous (IV) Iron Drugs Production, Consumption, Export, Import by Regions (2012-2017) 5.5 Japan Intravenous (IV) Iron Drugs Production, Consumption, Export, Import by Regions (2012-2017) 5.6 Southeast Asia Intravenous (IV) Iron Drugs Production, Consumption, Export, Import by Regions (2012-2017) 5.7 India Intravenous (IV) Iron Drugs Production, Consumption, Export, Import by Regions (2012-2017) Chapter 6 Global Intravenous (IV) Iron Drugs Production, Revenue (Value), Price Trend by Type 6.1 Global Intravenous (IV) Iron Drugs Production and Market Share by Type (2012-2017) 6.2 Global Intravenous (IV) Iron Drugs Revenue and Market Share by Type (2012-2017) 6.3 Global Intravenous (IV) Iron Drugs Price by Type (2012-2017) 6.4 Global Intravenous (IV) Iron Drugs Production Growth by Type (2012-2017) Chapter 7 Global Intravenous (IV) Iron Drugs Market Analysis by Application 7.1 Global Intravenous (IV) Iron Drugs Consumption and Market Share by Application (2012-2017) 7.2 Global Intravenous (IV) Iron Drugs Consumption Growth Rate by Application (2012-2017) 7.3 Market Drivers and Opportunities 7.3.1 Potential Applications 7.3.2 Emerging Markets/Countries Chapter 8 Global Intravenous (IV) Iron Drugs Manufacturers Analysis 8.1 AMAG Pharmaceuticals 8.1.1 Company Basic Information, Manufacturing Base and Competitors 8.1.2 Product Type, Application and Specification 8.1.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.1.4 Business Overview 8.2 Actavis 8.2.1 Company Basic Information, Manufacturing Base and Competitors 8.2.2 Product Type, Application and Specification 8.2.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.2.4 Business Overview 8.3 Galenica 8.3.1 Company Basic Information, Manufacturing Base and Competitors 8.3.2 Product Type, Application and Specification 8.3.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.3.4 Business Overview 8.4 Vifor Pharma 8.4.1 Company Basic Information, Manufacturing Base and Competitors 8.4.2 Product Type, Application and Specification 8.4.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.4.4 Business Overview 8.5 Luitpold Pharmaceuticals 8.5.1 Company Basic Information, Manufacturing Base and Competitors 8.5.2 Product Type, Application and Specification 8.5.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.5.4 Business Overview 8.6 Pharmacosmos A/S 8.6.1 Company Basic Information, Manufacturing Base and Competitors 8.6.2 Product Type, Application and Specification 8.6.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.6.4 Business Overview 8.7 American Regent 8.7.1 Company Basic Information, Manufacturing Base and Competitors 8.7.2 Product Type, Application and Specification 8.7.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.7.4 Business Overview 8.8 Fresenius Medical Care AG & Co. KGaA 8.8.1 Company Basic Information, Manufacturing Base and Competitors 8.8.2 Product Type, Application and Specification 8.8.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.8.4 Business Overview 8.9 Anofi US 8.9.1 Company Basic Information, Manufacturing Base and Competitors 8.9.2 Product Type, Application and Specification 8.9.3 Production, Revenue, Price and Gross Margin (2012-2017) 8.9.4 Business Overview … Chapter 9 Intravenous (IV) Iron Drugs Manufacturing Cost Analysis 9.1 Intravenous (IV) Iron Drugs Key Raw Materials Analysis 9.1.1 Key Raw Materials 9.1.2 Price Trend of Key Raw Materials 9.1.3 Key Suppliers of Raw Materials 9.1.4 Market Concentration Rate of Raw Materials 9.2 Proportion of Manufacturing Cost Structure 9.2.1 Raw Materials 9.2.2 Labor Cost 9.2.3 Manufacturing Expenses 9.3 Manufacturing Process Analysis of Intravenous (IV) Iron Drugs Chapter 10 Industrial Chain, Sourcing Strategy and Downstream Buyers 10.1 Intravenous (IV) Iron Drugs Industrial Chain Analysis 10.2 Upstream Raw Materials Sourcing 10.3 Raw Materials Sources of Intravenous (IV) Iron Drugs Major Manufacturers in 2015 10.4 Downstream Buyers Chapter 11 Marketing Strategy Analysis, Distributors/Traders 11.1 Marketing Channel 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Development Trend 11.2 Market Positioning 11.2.1 Pricing Strategy 11.2.2 Brand Strategy 11.2.3 Target Client 11.3 Distributors/Traders List Chapter 12 Market Effect Factors Analysis 12.1 Technology Progress/Risk 12.1.1 Substitutes Threat 12.1.2 Technology Progress in Related Industry 12.2 Consumer Needs/Customer Preference Change 12.3 Economic/Political Environmental Change Chapter 13 Global Intravenous (IV) Iron Drugs Market Forecast (2017-2021) 13.1 Global Intravenous (IV) Iron Drugs Production, Revenue Forecast (2017-2021) 13.2 Global Intravenous (IV) Iron Drugs Production, Consumption Forecast by Regions (2017-2021) 13.3 Global Intravenous (IV) Iron Drugs Production Forecast by Type (2017-2021) 13.4 Global Intravenous (IV) Iron Drugs Consumption Forecast by Application (2017-2021) 13.5 Intravenous (IV) Iron Drugs Price Forecast (2017-2021) Chapter 14 Appendix

Figure Picture of Intravenous (IV) Iron Drugs Figure Global Production Market Share of Intravenous (IV) Iron Drugs by Type in 2015 Figure Product Picture of Type I Table Major Manufacturers of Type I Figure Product Picture of Type II Table Major Manufacturers of Type II Figure Product Picture of Type III Table Major Manufacturers of Type III Table Intravenous (IV) Iron Drugs Consumption Market Share by Application in 2015 Figure Application 1 Examples Figure Application 2 Examples Figure Application 3 Examples Figure North America Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate (2012-2021) Figure Europe Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate (2012-2021) Figure China Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate (2012-2021) Figure Japan Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate (2012-2021) Figure Southeast Asia Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate (2012-2021) Figure India Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate (2012-2021) Figure Global Intravenous (IV) Iron Drugs Revenue (Million UDS) and Growth Rate (2012-2021) Table Global Intravenous (IV) Iron Drugs Capacity of Key Manufacturers (2015 and 2016) Table Global Intravenous (IV) Iron Drugs Capacity Market Share by Manufacturers (2015 and 2016) Figure Global Intravenous (IV) Iron Drugs Capacity of Key Manufacturers in 2015 Figure Global Intravenous (IV) Iron Drugs Capacity of Key Manufacturers in 2016 Table Global Intravenous (IV) Iron Drugs Production of Key Manufacturers (2015 and 2016) Table Global Intravenous (IV) Iron Drugs Production Share by Manufacturers (2015 and 2016) Figure 2015 Intravenous (IV) Iron Drugs Production Share by Manufacturers Figure 2016 Intravenous (IV) Iron Drugs Production Share by Manufacturers Table Global Intravenous (IV) Iron Drugs Revenue (Million USD) by Manufacturers (2015 and 2016) Table Global Intravenous (IV) Iron Drugs Revenue Share by Manufacturers (2015 and 2016) Table 2015 Global Intravenous (IV) Iron Drugs Revenue Share by Manufacturers Table 2016 Global Intravenous (IV) Iron Drugs Revenue Share by Manufacturers Table Global Market Intravenous (IV) Iron Drugs Average Price of Key Manufacturers (2015 and 2016) Figure Global Market Intravenous (IV) Iron Drugs Average Price of Key Manufacturers in 2015 Table Manufacturers Intravenous (IV) Iron Drugs Manufacturing Base Distribution and Sales Area Table Manufacturers Intravenous (IV) Iron Drugs Product Type Figure Intravenous (IV) Iron Drugs Market Share of Top 3 Manufacturers Figure Intravenous (IV) Iron Drugs Market Share of Top 5 Manufacturers Table Global Intravenous (IV) Iron Drugs Capacity by Regions (2012-2017) Figure Global Intravenous (IV) Iron Drugs Capacity Market Share by Regions (2012-2017) Figure Global Intravenous (IV) Iron Drugs Capacity Market Share by Regions (2012-2017) Figure 2015 Global Intravenous (IV) Iron Drugs Capacity Market Share by Regions Table Global Intravenous (IV) Iron Drugs Production by Regions (2012-2017) Figure Global Intravenous (IV) Iron Drugs Production and Market Share by Regions (2012-2017) Figure Global Intravenous (IV) Iron Drugs Production Market Share by Regions (2012-2017) Figure 2015 Global Intravenous (IV) Iron Drugs Production Market Share by Regions Table Global Intravenous (IV) Iron Drugs Revenue by Regions (2012-2017) Table Global Intravenous (IV) Iron Drugs Revenue Market Share by Regions (2012-2017) Table 2015 Global Intravenous (IV) Iron Drugs Revenue Market Share by Regions Table Global Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table North America Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Europe Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table China Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Japan Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Southeast Asia Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table India Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Global Intravenous (IV) Iron Drugs Consumption Market by Regions (2012-2017) Table Global Intravenous (IV) Iron Drugs Consumption Market Share by Regions (2012-2017) Figure Global Intravenous (IV) Iron Drugs Consumption Market Share by Regions (2012-2017) Figure 2015 Global Intravenous (IV) Iron Drugs Consumption Market Share by Regions Table North America Intravenous (IV) Iron Drugs Production, Consumption, Import & Export (2012-2017) Table Europe Intravenous (IV) Iron Drugs Production, Consumption, Import & Export (2012-2017) Table China Intravenous (IV) Iron Drugs Production, Consumption, Import & Export (2012-2017) Table Japan Intravenous (IV) Iron Drugs Production, Consumption, Import & Export (2012-2017) Table Southeast Asia Intravenous (IV) Iron Drugs Production, Consumption, Import & Export (2012-2017) Table India Intravenous (IV) Iron Drugs Production, Consumption, Import & Export (2012-2017) Table Global Intravenous (IV) Iron Drugs Production by Type (2012-2017) Table Global Intravenous (IV) Iron Drugs Production Share by Type (2012-2017) Figure Production Market Share of Intravenous (IV) Iron Drugs by Type (2012-2017) Figure 2015 Production Market Share of Intravenous (IV) Iron Drugs by Type Table Global Intravenous (IV) Iron Drugs Revenue by Type (2012-2017) Table Global Intravenous (IV) Iron Drugs Revenue Share by Type (2012-2017) Figure Production Revenue Share of Intravenous (IV) Iron Drugs by Type (2012-2017) Figure 2015 Revenue Market Share of Intravenous (IV) Iron Drugs by Type Table Global Intravenous (IV) Iron Drugs Price by Type (2012-2017) Figure Global Intravenous (IV) Iron Drugs Production Growth by Type (2012-2017) Table Global Intravenous (IV) Iron Drugs Consumption by Application (2012-2017) Table Global Intravenous (IV) Iron Drugs Consumption Market Share by Application (2012-2017) Figure Global Intravenous (IV) Iron Drugs Consumption Market Share by Application in 2015 Table Global Intravenous (IV) Iron Drugs Consumption Growth Rate by Application (2012-2017) Figure Global Intravenous (IV) Iron Drugs Consumption Growth Rate by Application (2012-2017) Table AMAG Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors Table AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Market Share (2012-2017) Table Actavis Basic Information, Manufacturing Base, Production Area and Its Competitors Table Actavis Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Actavis Intravenous (IV) Iron Drugs Market Share (2012-2017) Table Galenica Basic Information, Manufacturing Base, Production Area and Its Competitors Table Galenica Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Galenica Intravenous (IV) Iron Drugs Market Share (2012-2017) Table Vifor Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors Table Vifor Pharma Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Vifor Pharma Intravenous (IV) Iron Drugs Market Share (2012-2017) Table Luitpold Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors Table Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Market Share (2012-2017) Table Pharmacosmos A/S Basic Information, Manufacturing Base, Production Area and Its Competitors Table Pharmacosmos A/S Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Pharmacosmos A/S Intravenous (IV) Iron Drugs Market Share (2012-2017) Table American Regent Basic Information, Manufacturing Base, Production Area and Its Competitors Table American Regent Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table American Regent Intravenous (IV) Iron Drugs Market Share (2012-2017) Table Fresenius Medical Care AG & Co. KGaA Basic Information, Manufacturing Base, Production Area and Its Competitors Table Fresenius Medical Care AG & Co. KGaA Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Fresenius Medical Care AG & Co. KGaA Intravenous (IV) Iron Drugs Market Share (2012-2017) Table Anofi US Basic Information, Manufacturing Base, Production Area and Its Competitors Table Anofi US Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017) Table Anofi US Intravenous (IV) Iron Drugs Market Share (2012-2017) … Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Intravenous (IV) Iron Drugs Figure Manufacturing Process Analysis of Intravenous (IV) Iron Drugs Figure Intravenous (IV) Iron Drugs Industrial Chain Analysis Table Raw Materials Sources of Intravenous (IV) Iron Drugs Major Manufacturers in 2015 Table Major Buyers of Intravenous (IV) Iron Drugs Table Distributors/Traders List Figure Global Intravenous (IV) Iron Drugs Production and Growth Rate Forecast (2017-2021) Figure Global Intravenous (IV) Iron Drugs Revenue and Growth Rate Forecast (2017-2021) Table Global Intravenous (IV) Iron Drugs Production Forecast by Regions (2017-2021) Table Global Intravenous (IV) Iron Drugs Consumption Forecast by Regions (2017-2021) Table Global Intravenous (IV) Iron Drugs Production Forecast by Type (2017-2021) Table Global Intravenous (IV) Iron Drugs Consumption Forecast by Application (2017-2021)

AMAG Pharmaceuticals Actavis Galenica Vifor Pharma Luitpold Pharmaceuticals Pharmacosmos A/S American Regent Fresenius Medical Care AG & Co. KGaA Anofi US Takeda Pharmaceutical